Methylamine → HCID 23660829, compound

HRID 1435478Notes

Reaction equation

HRID 1435478 reaction equation
[CH3:1][N:2](C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN.C1COCC1.CCN(C(C)C)C(C)C.[C:41]([C:45]1[N:49]([CH2:50][CH:51]2[CH2:56][CH2:55][O:54][CH2:53][CH2:52]2)[C:48]2[CH:57]=[CH:58][C:59]([S:61]([N:64]3[CH:68]=[C:67]([C:69]([OH:71])=O)[CH:66]=[N:65]3)(=[O:63])=[O:62])=[CH:60][C:47]=2[N:46]=1)([CH3:44])([CH3:43])[CH3:42]>CN(C=O)C>[C:41]([C:45]1[N:49]([CH2:50][CH:51]2[CH2:52][CH2:53][O:54][CH2:55][CH2:56]2)[C:48]2[CH:57]=[CH:58][C:59]([S:61]([N:64]3[CH:68]=[C:67]([C:69]([NH:2][CH3:1])=[O:71])[CH:66]=[N:65]3)(=[O:62])=[O:63])=[CH:60][C:47]=2[N:46]=1)([CH3:44])([CH3:43])[CH3:42]

Participants

7

Procedure

Following the same procedure in Example 24, Step A, using HATU (37 mg, 0.09 mmol), methylamine in THF (0.07 mL, 2M, 0.14 mmol), DIPEA (0.02 mL, 0.10 mmol) and 1-{[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]sulfonyl}-1H-pyrazole-4-carboxylic acid (40 mg, 0.09 mmol) (see following step B for preparation) in DMF (5 mL). The crude product was purified by MPLC on silica gel using EtOAc/DCM (1:1) to provide the title compound as a white solid. The product was converted to its TFA salt. Yield: 15 mg (29%); 1H NMR (400 MHz, CD3OD) δ 1.38-1.46 (m, 2 H), 1.46-1.54 (m, 2 H), 1.54-1.59 (s, 9 H), 2.22-2.36 (m, 1 H), 2.83 (s, 3 H), 3.25-3.35 (m, 2 H), 3.89 (dd, J=11.43, 3.61 Hz, 2 H), 4.36 (d, J=7.42 Hz, 2 H), 7.79 (d, J=8.59 Hz, 1 H), 7.90 (dd, J=8.69, 1.86 Hz, 1 H), 8.01 (s, 1 H), 8.29 (d, J=1.95 Hz, 1 H), 8.72 (s, 1 H); MS (ESI) (M+H)+=459.8; Anal. Calcd for C22H29N5O4S+0.1H2O: C, 57.27; H, 6.38; N, 15.18. Found: C, 57.49; H, 6.55; N, 14.34.

Workup

  1. customThe crude product was purified by MPLC on silica gel

Sources & evidence

ORD record
ord-6797b338c85c482ba60e2c672ac8b320
Source dataset
uspto-grants-2009_11
Patent number
US07615642B2

Reaction notes

Loading…